27
9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T15362 | FX-11 | LDHA Inhibitor FX11 | Dehydrogenase |
FX-11 (LDHA Inhibitor FX11) is A potent, selective and competitive specific inhibitor of lactate dehydrogenase A (LDHA) with a Ki of 8 μM. FX-11 can activate PKM2 (pyruvate kinase M2). FX-11 can reduce ATP levels, induce... | |||
T7582 | Tafamidis meglumine | Fx-1006A | Others |
Tafamidis meglumine (Fx-1006A) is a Potent and Selective Transthyretin Kinetic Stabilizer That Inhibits the Amyloid Cascade | |||
T4565 | Tafamidis | Fx-1006A | Others |
Tafamidis (Fx-1006A) is a kinetic stabilizer of transthyretin (TTR) that prevents amyloidogenesis by wild-type and mutant TTRs. It binds to TTR with negative cooperativity (Kd1: 3 nM; Kd2: 278 nM) to stabilize the TTR di... | |||
T78562 | FX-06 | Fibrin-derived peptide Bβ15-42 | |
FX-06 (Fibrin-derived peptide Bβ15-42) is a peptide derived from the fibrin Bbeta chain. It interacts with VE-cadherin to inhibit leukocyte transmigration and initiate VE-cadherin-mediated signaling pathways. This compou... | |||
T4089 | FX1 | Apoptosis , BCL | |
FX1 is an effective and selective BCL6 inhibitor (IC50: 35 μM). | |||
T73519 | FX-909 | ||
FX-909 is a covalent peroxisome proliferator-activated receptor gamma ( PPARG ) inverse agonist. FX-909 can be used for the research of cancer . | |||
T9253 | CPFX4158 | Antibacterial | |
CPFX4158 is a mannose deriviative and an antibacterial agent that is potentially useful in transgenic humanized- CEACAM6 mouse. | |||
T72889 | FXR agonist 4 | ||
FXR agonist 4 with an EC 50 value of 1.05 μM. FXR agonist 4 effectively improves hyperlipidemia, hepatic steatosis, insulin resistance and hepatic inflammation in DIO mice. FXR agonist 4 can be used for the research of ... | |||
T39035 | FXIa-IN-6 | ||
FXIa-IN-6 is a potent FXIa inhibitor with selectivity against most of the relevant serine proteases ( K i = 0.3 nM). FXIa-IN-6 also demonstrated excellent pharmacokinetics (PK) profile (high oral bioavailability and low ... | |||
T11341 | FXIa-IN-1 | Others | |
FXIa-IN-1 is a potent β-lactam covalent heparin-derived factor XIa (fXIa) inhibitor. | |||
T74996 | FXR agonist 3 | ||
FXR agonist 3, an anti-NASH (Non-Alcoholic Steatohepatitis) agent, functions by activating FXR. It demonstrates anti-fibrogenic activity by inhibiting the expression of COL1A1, TGF-β1, α-SMA, and TIMP1. Additionally, it ... | |||
T82361 | FXIIa-IN-1 | ||
XIIa-IN-1-IN-3 (Compound 22) is a Factor XIIa inhibitor with an apparent inhibition constant (K i app) of 97.8 nM, utilized in the study of thrombosis [1]. | |||
T82360 | FXIIa-IN-2 | ||
XIIa-IN-1-IN-2 (Compound 21) serves as a potent Factor XIIa inhibitor with an apparent inhibition constant (K i app) of 62.2 nM, utilized primarily in thrombosis research [1]. | |||
T64098 | FXIa-IN-10 | ||
FXIa-IN-10 is a potent, orally bioavailable inhibitor of Activator XI (FXIa) (Ki: 0.17 nM). | |||
T70458 | FXIa-6f | ||
FXIa-6f is a high affinity, orally bioavailable macrocyclic FXIa inhibitor with antithrombotic activity in preclinical species | |||
T64099 | FXIa-IN-9 | ||
FXIa-IN-9 (compound 3f) is a potent, selective inhibitor of FXIa, demonstrating strong binding affinity through hydrogen bond formation (human FXIa K i : 0.17 nM, rabbit FXIa K i : 0.5 nM). It exhibits anticoagulant prop... | |||
T10878 | CPFX2090 | Others | |
CPFX2090, a cephalosporin antibacterial compound. | |||
T64144 | FXR antagonist 1 | ||
FXR antagonist 1 is a selective, orally active intestinal FXR antagonist with an IC50 value of 2.1 μM. FXR antagonist 1 antagonises intestinal FXR and selectively inhibits intestinal FXR signalling by feedback activation... | |||
T64257 | FXIa-IN-8 | ||
FXIa-IN-8 is a potent and selective inhibitor of FXIa (IC50: 14.2 nM). FXIa-IN-8 exhibits anti-thrombotic effects and does not increase the risk of bleeding or significant toxicity sup>[1]. | |||
T75160 | FXR agonist 5 | ||
FXR agonist 5 (compound 1), an FXR agonist, is utilized in research targeting diseases or disorders associated with metabolic inflammation [1]. | |||
T74754 | FXR antagonist 2 | ||
Compound A-26, also known as FXR antagonist 2, is a diarylamide derivative that functions as a moderate FXR antagonist. It is utilized in researching hyperlipidemia and type 2 diabetes [1]. | |||
T40302 | FXR/TGR5 agonist 1 | ||
FXR/TGR5 agonist 1 acts as an agonist on both FXR and TGR5 receptors and is utilized for treating fatty liver disease. | |||
T62832 | FXIa-IN-7 | ||
FXIa-IN-7 is an orally active, selective factor Xia inhibitor (IC50: 0.4 nM). | |||
T63239 | FXa-IN-1 | ||
FXa-IN-1 is an FXa inhibitor with an IC50 value of 3 nM and a Ki value of 0.7 nM that exhibits good oral bioavailability and half-life (in vivo) and can be used to study thromboembolic diseases. | |||
T82585 | Denecimig | Mim8 | Factor Xa |
Denecimig (Mim8), a novel bispecific human antibody mimetic of activated coagulation factor VIII, possesses both anti-FIXa and anti-FX arms. This compound robustly enhances FX activation, thereby promoting effective hemo... | |||
T26394 | 6-Alkynyl-fucose | 6-Alk-Fuc | |
6-Alkynyl-fucose, a widely used fucosylation probe, acts by strongly inhibiting fucosylation and GDP-fucose synthetase FX and halting hepatoma invasion. | |||
T71641 | BMS-593214 | ||
BMS-593214 is an active site-directed factor (F) VIIa inhibitor that exhibits antithrombotic and antihaemostatic properties. It acts as a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of Vii... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01101 | Coagulation factor X/F10 Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
Coagulation factor X, also known as FX, F10, Eponym Stuart-Prower factor, and thrombokinase, is an enzyme of the coagulation cascade. It is one of the vitamin K-dependent serine proteases, and plays a crucial role in the... | |||
TMPJ-01111 | TSTA3 Protein, Human, Recombinant (His) | Human | E. coli |
GDP-L-Fucose Synthase is a NADP(H)-binding protein. It catalyzes the two-step epimerase and the reductase reactions in GDP-D-mannose metabolism, converting GDP-4-keto-6-D-dexoymannose to GDP-L-fucose. GDP-L-Fucose is the... | |||
TMPH-03295 | Frataxin/FXN Protein, Rat, Recombinant | Rat | E. coli |
Frataxin/FXN Protein, Rat, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18.6 kDa and the accession number is D3ZYW7. | |||
TMPH-02660 | Frataxin/FXN Protein, Mouse, Recombinant (His) | Mouse | P. pastoris (Yeast) |
Promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe(2+) to proteins involved in these pathways. May play a role in the protection against iron-catalyzed oxidative stress thr... | |||
TMPH-02661 | Frataxin/FXN Protein, Mouse, Recombinant (E. coli, His) | Mouse | E. coli |
Promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe(2+) to proteins involved in these pathways. May play a role in the protection against iron-catalyzed oxidative stress thr... | |||
TMPH-01479 | H2AFX Protein, Human, Recombinant (GST) | Human | E. coli |
H2AFX Protein, Human, Recombinant (GST) is expressed in E. coli. | |||
TMPH-01355 | FXR1 Protein, Human, Recombinant (His) | Human | E. coli |
RNA-binding protein required for embryonic and postnatal development of muscle tissue. May regulate intracellular transport and local translation of certain mRNAs. FXR1 Protein, Human, Recombinant (His) is expressed in E... | |||
TMPH-01358 | FXYD3 Protein, Human, Recombinant (His & SUMO) | Human | E. coli |
FXYD3 Protein, Human, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 20.5 kDa and the accession number is Q14802. | |||
TMPH-01356 | Frataxin/FXN Protein, Human, Recombinant (His & Myc) | Human | E. coli |
Frataxin/FXN Protein, Human, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 28.1 kDa and the accession number is Q16595. |